SCIENTIFIC ADVISORY AND CONSULTING AGREEMENTScientific Advisory and Consulting Agreement • August 14th, 2008 • Pipex Pharmaceuticals, Inc. • Pharmaceutical preparations
This Scientific Advisory and Consulting Agreement (this "Agreement'') dated July, 2nd, 2008 (the "Effective Date"), between Epitope Pharmaceuticals, Inc., a corporation (the "Company'" or "EPI') and Archimedes Consulting, inc, a California corporation wholly owned by Salvatore Albani, MD. Ph.D. ("Inventor'') having place of business at 629 4th Street in Encinitas, California, 92024.''Consultant'',
LICENSE AGREEMENT BETWEEN EPITOPE PHARMACEUTICALS, INC. AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FOR CASE NO. SD2006-256, SD2002-051, SD2001-901, SD2000-133, SD1993-268License Agreement • August 14th, 2008 • Pipex Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This agreement ("Agreement") is made by and between Epitope Pharmaceuticals, Inc. (EPI), a Delaware corporation having an address at 9100 South Dadeland Blvd, Suite 1809, Miami, FL 33156 ("LICENSEE") and The Regents of the University of California, a California corporation having its statewide administrative offices at 1111 Franklin Street, Oakland, California 94607-5200 ("UNIVERSITY"), represented by its San Diego campus having an address at University of California, San Diego, Technology Transfer & Intellectual Property Services, Mail Code 0910, 9500 Gilman Drive, La Jolla, California 92093-0910 ("UCSD").
